Newsroom

DUBLIN--(BUSINESS WIRE)--Brera Holdings PLC, operating under the name Solmate Infrastructure (the “Company”) (NASDAQ: SLMT) today disclosed that on April 23, 2026, the Company received a written determination letter (the “Staff Determination”) from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that the Staff has determined to delist the Company’s Class B ordinary shares, $0.005 nominal value per share (“Ordinary Shares”), from The Nasdaq Capit...

SAN DIEGO--(BUSINESS WIRE)--RevolutionEHR launches AI Scribe, capturing exam notes in real time to help finish charts faster, reduce after-hours work, and focus on patient care....

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers and acquirers of Globant S.A. (NYSE: GLOB) common stock between February 15, 2024 and August 14, 2025, inclusive (the “Class Period”). Globant is an international technology company. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations that Globant S.A...

PLANO, Texas--(BUSINESS WIRE)--Sally Beauty Holdings, Inc. (NYSE:SBH) (the “Company”), the leader in professional hair color, announced today that it will host a conference call and webcast on May 11, 2026, at 7:30 a.m. Central Time, to discuss its second quarter financial results. A copy of the press release announcing the second quarter financial results is expected to be made available on May 11, 2026, before the U.S. financial markets open on the Company's website sallybeautyholdings.com/in...

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired SES AI Corporation (NYSE: SES) securities between January 29, 2025 and March 4, 2026. SES claims to be a "leading developer and manufacturer of high-performance, AI-enhanced Lithium-Metal (“Li-Metal”) and Lithium-ion (“Li-ion”) rechargeable battery technologies and battery materials for Energy Storage Systems (“ESS”), Urban Air Mobility (“UAM”)...

NEW YORK--(BUSINESS WIRE)--Ladenburg Thalmann & Co. Inc. (“Ladenburg Thalmann”), a leading middle-market investment bank providing investment banking, equity research, and institutional sales and trading services, today announced that Aydin Huseynov, M.D., CFA, has joined the firm's Healthcare Investment Banking Group as Managing Director, Biotechnology Investment Banking Specialist. Dr. Huseynov will focus on the continued expansion of Ladenburg's biotechnology investment banking platform...

DALLAS--(BUSINESS WIRE)--CBRE Group, Inc. (NYSE:CBRE) (the “Company”) today announced the pricing of the offering of $750,000,000 aggregate principal amount of 5.250% Senior Notes due 2036 (the “Notes”). The Notes will have an interest rate of 5.250% per annum and are being issued at a price equal to 98.947% of their face value. The Company’s wholly owned subsidiary, CBRE Services, Inc. (“Services”), will issue the Notes, which will be guaranteed on a full and unconditional basis by the Company...

LOS ANGELES--(BUSINESS WIRE)--AHF's Gilead Shareholder Resolution Seeks Transparency on Patent Exclusivities...

NEW YORK--(BUSINESS WIRE)--KBRA is pleased to announce the assignment of preliminary ratings to 15 classes of Benchmark 2026-B43, a $683.2 million CMBS conduit transaction collateralized by 31 commercial mortgage loans secured by 53 properties. The collateral properties are located throughout 26 MSAs, of which the three largest are New York (20.2% of pool balance), Washington - NoVA - MD (12.1%), and Cleveland (7.9%). The pool has exposure to all major property types, with four types representi...

FILADÉLFIA--(BUSINESS WIRE)--A PCI Pharma Services (“PCI”) – uma organização global integrada de desenvolvimento e fabricação por contrato (CDMO) líder mundial, focada em terapias inovadoras de moléculas pequenas e biológicas – anunciou uma série de grandes investimentos em infraestrutura que aprofundam substancialmente suas capacidades de envase estéril e administração avançada de medicamentos. À medida que os fabricantes farmacêuticos e seus parceiros de desenvolvimento priorizam cada vez mai...